Autopsy report · NCT05992168
Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)
Cause of deathFunding or business
“The clinical trial was terminated ahead of schedule due to strategic changes within the company.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 11 months before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Suzhou Zenith Vascular SciTech Limited
- Sponsor type
- Industry
- Conditions
- PE - Pulmonary Embolism; PE - Pulmonary Thromboembolism
- Interventions
- Stent-Retriever
- Participants
- 1
- Sites
- 1
- Countries
- China
Trials that died the same way
- INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
“Terminated due to clinical trial material production delays” - Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
“The study was terminated due to the sponsor's decision to discontinue the clinical trial.” - Phase II Study of TAEST16001 in Soft Tissue Sarcoma
“The study was terminated due to initiation of a new clinical trial with an updated study design.” - A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
“The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.” - Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors
“Trial terminated due to business decision, not based on any safety or efficacy concerns.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.